Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 3 art units • 4 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Cmpd Licensing LLC has 6 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 4 distinct examiners, which indicates that some examiners are reviewing multiple cases for the company. The prosecution is spread across 3 distinct art units, showing a moderate level of technical diversity within the biotechnology field. This distribution requires the company to manage four different examiner relationships across three separate technical groups at the USPTO.
KAMM, JUDITH MARIE is the busiest examiner for the company, with 2 pending office actions. This accounts for 2 of the 6 pending office actions currently active. With 4 distinct examiners and 3 distinct art units, the company must manage a small but varied group of examiner perspectives and technical review standards. The presence of 4 distinct examiners for 6 pending office actions suggests a level of examiner consistency, as some examiners are responsible for more than one of the company's biotechnological applications across the 3 distinct art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAMM, JUDITH MARIE | 2 | 43.5% | +56.6% |
| LEE, ANDREW P | 2 | 48.3% | +23.1% |
| CHICKS, ASHLI ARIANA | 1 | 60.6% | +50.3% |
| LANDAU, SHARMILA GOLLAMUDI | 1 | 11.1% | +4.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18583611 | NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS | LANDAU, SHARMILA GOLLAMUDI | 28d |
| 19067198 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19067198 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | — |
| 19067153 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | — |
| 18902141 | COMPOSITION AND METHOD FOR TREATING FUNGAL SKIN CONDITIONS AND INFLAMMATION | CHICKS, ASHLI ARIANA | — |
| 18119724 | TOPICAL COMPOSITIONS AND METHODS OF FORMULATING SAME | LEE, ANDREW P | — |
| 17728078 | TOPICAL COMPOSITIONS AND METHODS OF FORMULATING THE SAME | LEE, ANDREW P | — |
| Art Unit | Apps |
|---|---|
| 1611 | 2 |
| 1691 | 2 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19067198 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | 1611 | §103§112Other | Final Rejection | — | Pending | Feb 28, 2025 |
| 19067153 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | 1611 | §103Other | Final Rejection | — | Pending | Feb 28, 2025 |
| 18902141 | COMPOSITION AND METHOD FOR TREATING FUNGAL SKIN CONDITIONS AND INFLAMMATION | CHICKS, ASHLI ARIANA | — | §112DP | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18583611 | NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS | LANDAU, SHARMILA GOLLAMUDI | 1653 | §103 | Final Rejection | 28d | Pending | Feb 21, 2024 |
| 18119724 | TOPICAL COMPOSITIONS AND METHODS OF FORMULATING SAME | LEE, ANDREW P | 1691 | §103 | Non-Final OA | — | Pending | Mar 09, 2023 |
| 17728078 | TOPICAL COMPOSITIONS AND METHODS OF FORMULATING THE SAME | LEE, ANDREW P | 1691 | §103 | Final Rejection | — | Pending | Apr 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial